Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 38.91
0.569 %
$ 2.15 B
Market Cap
36.36
P/E
SUPN - STOCK-BASED COMPENSATION
Stock-based Compensation SUPN - Supernus Pharmaceuticals, Inc.
26.8 M
LAST VALUE
22.23%
2 YEAR CAGR
18.84%
5 YEAR CAGR
30.19%
10 YEAR CAGR